Get our news on your inbox! x

Remember me Forgot password

MercoPress, en Español

Montevideo, November 22nd 2024 - 11:39 UTC

Tag: Frank Bennett

  • Wednesday, December 13th 2017 - 22:08 UTC

    “Ground break” in tackling protein defect that causes Huntington's disease

    Lead researcher Prof. Sarah Tabrizi, from University College London, said the drug's capacity to lower levels of a toxic protein was “ground-breaking”.

    Scientists have for the first time corrected a protein defect that causes Huntington's disease, by injecting a drug into the spine, offering new hope for patients with the devastating genetic disease. Lead researcher Sarah Tabrizi, professor of clinical neurology at University College London, said the ability of the drug to tackle the underlying cause of Huntington's by lowering levels of a toxic protein was “ground-breaking”.